LogicBio Therapeutics Announces Research Collaboration with Daiichi Sankyo
- SBIJI Innovation
- Apr 28, 2021
- 1 min read
- Under the terms of the research collaboration and exclusive option agreement, the companies will initiate a gene editing research program dedicated to the treatment of two early onset indications with high unmet need, leveraging the GeneRide™ platform -
Comments